Open AccessPHASE 2 STUDY DESIGN EVALUATING EFFICACY, SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ANTI-CD40 MONOCLONAL ANTIBODY CFZ533 (ISCALIMAB) IN DE NOVO LIVER TRANSPLANT RECIPIENTS: THE CONTRAIL I STUDY
Author(s) -
Björn Nashan,
Stuart J. Knechtle,
Faouzi Saliba,
Ute Laessing,
Pascal Espié,
Jan Klatt,
Sandy Feng
Publication year - 2020
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/01.tp.0000698704.88369.27
Subject(s) - medicine , tolerability , pharmacokinetics , calcineurin , pharmacodynamics , liver transplantation , renal function , urology , transplantation , regimen , tacrolimus , pharmacology , gastroenterology , adverse effect